201 – 210 of 262
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
AAPS-FDA workshop white paper: Microdialysis principles, application, and regulatory perspectives report from the joint AAPS-FDA workshop, November 4-5, 2005, Nashville, TN
(
- Contribution to journal › Article
-
Mark
The impact of sub-cellular location and intracellular neuronal proteins on properties of GABA(A) receptors
(
- Contribution to journal › Article
-
Mark
Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate((R)) P/Humate-P((R))) in von Willebrand Disease and Haemophilia A: A Viewpoint by Eric Berntorp.
(
- Contribution to journal › Letter
-
Mark
Reaction of pyridine N-oxides with Grignard reagents : a stereodefined synthesis of substituted dienal oximes
(
- Contribution to journal › Article
-
Mark
Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Delayed-release Multi Matrix System (MMX (TM)) mesalazine in ulcerative colitis - A viewpoint by Ake Nilsson
(
- Contribution to journal › Debate/Note/Editorial
- 2006
-
Mark
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
(
- Contribution to journal › Article
-
Mark
Effects of Sodium Taurocholate on the Absorption of Inhaled (99m)Tc-DTPA.
(
- Contribution to journal › Article
-
Mark
Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.
(
- Contribution to journal › Article
-
Mark
Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML
(
- Contribution to journal › Article